Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 13
Submit an article Journal homepage
30
Views
2
CrossRef citations to date
0
Altmetric
Review

Cardiovascular system as a ‘core’ of sexual life

Ahmed I El-Sakka Andrology Clinic, Al-Noor Specialist Hospital, PO Box 6251, Makkah, Saudi Arabia. [email protected]; Suez Canal University, Ismailia, Egypt
Pages 2223-2230 | Published online: 12 Oct 2005

Bibliography

  • LUE TF, TANAGHO EA: Physiology of erection and pharmacological management of impotence. J. Uri)] (1987) 137(5):829–836.
  • •One of the early studies that described the mechanism of erection.
  • ABOSEIF SR, BREZA J, LUE TF, TANAGHO EA: Penile venous drainage in erectile dysfunction. Anatomical, radiological and functional considerations. Br. J. Uri)] (1989) 64(2):183–190.
  • SAENZ DE TEJADA I, CARSON MP, DE LAS MORENAS A, GOLDSTEIN I, TRAISH AM: Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Ain. Physiol (1991) 261:H1078–H1085.
  • IGNARRO LJ, BUSH PA, BUGA GM, WOOD KS, FUKUTO JM, RAJFER J: Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochein. Biophys. Res. Comm. (1990) 170:843–850.
  • HELLERSTEIN HK, FRIEDMAN EH: Sexual activity and the postcoronary patient. Arch. Intern. Med. (1970) 125(6):987–999.
  • BOHLEN JG, HELD JP, SANDERSON MO, PATTERSON RP: Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch. Intern. Med. (1984) 144(9):1745–1748.
  • ALPERT JS: Counselling the cardiac patient concerning coitus. Med. Aspects Hum. Sex. (1984) 18:204–207.
  • WAGNER NN, SIVARAJAN ES: Sexual activity and the cardiac patient. In: Human Sexuality: a Health Practitioner's Guide. R Green (Ed.), Williams & Wilkins, Baltimore, MD, USA (1979).
  • FOLKOW B: Sympathetic nervous control of blood pressure. Role in primary hypertension. Am. J. Hypertens. (1989) 2(3 Pt 2):1035-111S.
  • KONISHI M, SU C: Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension (1983) 5(6):881–886.
  • LINDER L, KIOWSKI W, BUHLER FR, LUSCHER TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 81(6):1762–1767.
  • FOLKOW B: 'Structural factor' in primary and secondary hypertension. Hypertension (1990) 16(1):89–101.
  • OKABE H, HALE TM, KUMON H, HEATON JP, ADAMS MA: The penis is not protected-in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int. J. Impot. Res. (1999) 11(3):l33–l40.
  • HALE TM, OKABE H, HEATON JP, ADAMS MA: Antihypertensive drugs induce structural remodeling of the penile vasculature. Uri)] (2001) 166(2):739–45.
  • EL-SAKKA Al: Characteristics of erectile dysfunction in Saudi patients. Int. I Impot. Res. (2004) 16(1):13–20.
  • BURCHARDT M, BURCHARDT T, BAER L et al.: Hypertension is associated with severe erectile dysfunction. Um]. (2000) 164:1188–1191.
  • •A good investigation that showed the association of hypertension with ED.
  • EL-SAKKA AI, MORSY AM: Screening for ischemic heart disease in patients with erectile dysfunction: role of penile doppler ultrasonography. Urology (2004) 64:346–350.
  • ••A well-controlled investigative study thatshowed the role of penile doppler ultrasonography in the prediction of IHD.
  • WEISS RJ: Effects of antihypertensive agents on sexual function. Am. Pam. Physician (1991) 44:2075–2082.
  • LLISTERRI JL, LOZANO VIDAL JV, AZNAR VICENTE J et al.: Sexual dysfunction in hypertensive patients treated with losartan. Am. J. Med. Sci. (2001) 32(5):336–341.
  • FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, MCKINLAY JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study../. Um]. (1994) 151:54–61.
  • GREENSTEIN A, CHEN J, MILLER H, MATZKIN H, VILLA Y, BRAF Z: Does severity of ischemic coronary disease correlate with erectile function? Lit. j Impot. Res. (1997) 9:123–126.
  • ••A well-designed study that investigatedthe correlation between severity of IHD and ED.
  • VIRAG, R, BOUILLY P, FRYDMAN D: Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet (1985) 26:181–184.
  • SHABSIGH R, FISHMAN IJ, SCHUM C, DUNN JK: Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology (1991) 38:227–231.
  • ZORGNIOTTI AW: Potency problems in cardiac patients and arteriopaths. In: Impotence Diagnosis and Management of Male Erectile Dysfunction. RS Kirby, C Carson, GD Webster (Eds), Butterworth Heinemann Ltd, Oxford, UK (1990:232.
  • EL-SAKKA Al, TAYEB KA: Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. J. Um]. (2003) 169:1043–1047.
  • KRANE RJ, GOLDSTEIN I, SAENZ DE TEJADA I: Impotence. N Engl. J. Med. (1989) 321(201648–1659.
  • ••A comprehensive overview that describedin detail the area of ED.
  • KAWANISHI Y, LEE KS, KIMURA K et al.: Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int. J. Impot. Res. (2001) 13:100–103.
  • EL-SAKKA Al, MORSY AM, FAGIH BI, NASSAR AH: Coronary artery risk factors in patients with erectile dysfunction. J. Urol. (2004) 172(1):251–254.
  • DERBY CA, MOHR BA, GOLDSTEIN I, FELDMAN HA, JOHANNES CB, MCKINLAY JB: Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology (2000) 56(2):302–306.
  • WAGNER G, FUGL-MEYER KS, FUGL-MEYER AR: Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int. J. Impot. Res. (2000) 12\(Suppl. 4):5144–5146.
  • CARLSSON R: Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme. Land. Cardiovasc. Suppl. (1998) 50:1–20.
  • GOLDSTEIN I: The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am. J. Cardiol (2000) 86(2A):41F–45F.
  • ••A good paper that showed the mutual relation between the three interacted diseases.
  • PARZELLER M, RASCHKA C, BRATZKE H: Sudden cardiovascular death in correlation with sexual activity - results of a medicolegal postmortem study from 1972-1998. Eur. Heart J. (2001) 22(7):610–611.
  • UENO M: The so-called coition death. Nippon Hoigaku Zasshi. (1963) 17:330–340.
  • MULLER JE, MITTLEMAN MA, MALCOLM M et al: Triggring myocardial infarction by sexual activity. JAMA (1996) 275:1405–1409.
  • ••An interesting study that showed therelationship between MI and sexual activity.
  • MULLER JE: Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. Am. J. Cardiol (2000) 86(2414F–18F.
  • PAPADOPOULOS C: Sexual problems of the CAD patient. Med. Aspects Hum. Sex. (1987) 21:53–56.
  • SCHAFFER WA, COBB LA: Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl. J. Med. (1975) 293(6):259–262.
  • KIMMEL SE: Sex and myocardial infarction: an epidemiologic perspective. Am. J. Cardiol (2000) 86(2A):10E–13F.
  • PIETROPINTO A, ARORA A: Sexual functioning with angina pectoris. Med. Aspects Hum. Sex. (1989) 23:100–106.
  • PIETROPINTO A: Post-myocardial infarction sexual functioning. Med. Aspects Hum. Sex. (1990) 24:57–60.
  • BONNER EJ, GENDEL ES: Sexual counselling for the elderly patient after myocardial infarction. Med. Aspects Hum. Sex. (1987) 21:100–108.
  • PAPADOPOULOS C: Coitus after heart attack. Med. Aspects Hum. Sex. (1986) 20:153–154.
  • HALE TM, OKABE H, BUSHFIELD TL, HEATON JP, ADAMS MA: Recovery of erectile function after brief aggressive antihypertensive therapy. J. Um]. (2002) 168(1):348–354.
  • SIMONSEN U: Interactions between drugsfor erectile dysfunction and drugs for cardiovascular disease. Int. J. Impot. Res.(2002) 14(3):178–188.
  • SHOCHET BR, LISANSKY ET, GRANT A et al.: Roundtable: sexual dysfunction in cardiac disease. Med. Aspects Hum. Sex.(1984) 18:170–186.
  • EL-SAKKA Al, LUE TF: Does a heart attack mean the end of sexual life? Am. College of Cardiol Educational Highlights (1996) 12(2):6–9.
  • •An interesting review that answered a clinically relevant question.
  • GOLDSTEIN I, LUE TF, PADMA-NATHAN H, ROSEN RC, STEERS WD, WICKER PA: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. (1998) 338(20):1397–1404.
  • BOOLELL M, GEPI-ATTEE S, GINGELL JC, ALLEN MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Um]. (1996) 78(2):257–261.
  • KLONER RA, MITCHELL M, EMMICK JT: Cardiovascular effects of tadalafil. Am. J. Cardiol (2003) 92(9437M–46M.
  • •An interesting paper that showed the cardiovascular effects of tadalafil.
  • TRAVERSE JH, CHEN YJ, DU R, BACHE RJ: Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise. Circulation (2000) 102(24):2997–3002.
  • JACKSON G, BENJAMIN N, JACKSON N, ALLEN MJ: Effects of sildenafil citrate on human hemodynamics. Am. J. Cardiol. (1999) 83(5A):13C–20C.
  • ••An important paper that investigated theeffects of sildenafil citrate on human haemodynamics.
  • HERRMANN HC, CHANG G, KLUGHERZ BD, MAHONEY PD: Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl. [Med. (2000) 342(22):1622–1626.
  • •A relevant paper that investigated the different haemodynamic effects of sildenafil in men with severe CAD.
  • CHEN Y, DU R, TRAVERSE JH, BACHE RJ: Effect of sildenafil on coronary active and reactive hyperemia. km J. Physic] Heart Circ. Physic] (2000) 279(5):H2319–H2325.
  • ROSANO GM, MARAZZI G, PATRIZI R et al.: Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. Am. J. Cardiol. (2005) 95(3):327–331.
  • SULLIVAN ME, THOMPSON CS, DASHWOOD MR et al: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. (1999) 43:658–665.
  • ••An interesting investigation described the relationship between ED and vascular diseases.
  • POLSON JB, STRADA SJ: Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol (1996) 36:403–427.
  • •Early investigation for PDEs.
  • BEAVO JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Res. (1995) 75:725–748.
  • ••Very interesting early investigation ofPDEs.
  • RYBALKIN SD, BRONFELDT KE, SONNENBURG WK et al.: Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic proliferative phenotype. J. Clin. Invest. (1997) 100:6211–6221.
  • FAWCETT L, BAXENDALE R, STACEY P et al.: Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDEILA. Proc. Natl. Acad. Sci. (2000) 97:3702–3707.
  • CHEITLIN MD, HUTTER AM Jr, BRINDIS RG et al.: Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation (1999) 99:168–177.
  • Sildenafil citrate (Viagra) prescribing information. Pfizer, New York, NY, USA (1999).
  • DEBUSK R, DRORY Y, GOLDSTEIN I et al: Management of sexual dysfunction in patients with cardiovascular disease. Recommendations of the Princeton Consensus panel. Am. J. Cardiol (2000) 86:62F–68F.
  • DRORY Y: Sexual activity and cardiovascular risk. Eur. Heart J. (2002) 4(Suppl. H):H13–H18.
  • ••An interesting review of the effects ofsexual activity on cardiovascular risk.
  • WOHL A: Sudden anginal pain. Med. Aspects Hum. Sex.(1990) 24:57–58.

Websites

  • http://www.duj.com/Article/Lue.html EL-SAKKA Al, LUE TF: Physiology of penile erection. Digital Urol. J. (1998)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.